We report a case of L. loa infection in a 29-year-old woman who presented with eyeworm, limb angioedema (Calabar swelling), rashes, and pruritus after she had traveled to the Democratic Republic of Congo and Central African Republic. She was referred for treatment under an institutional review board-approved protocol and was found to have an L. loa microfilarial level of 2250 microfilariae (mf) per milliliter. After the patient was administered a single 600-mg dose of imatinib, repeated concentrated peripheral blood smears showed a slow decline in microfilarial levels to a nadir of 150 mf per milliliter over a 6-day period (Fig. 1 ). Aside from a mild, transient headache that occurred after imatinib administration, the patient reported no new symptoms but noted a decrease in pruritus over the ensuing days. A blood smear obtained on day 11 showed that the microfilarial level had started to increase again (392 mf per milliliter), and she was given definitive treatment for L. loa infection with diethylcarbamazine.
A previous study showed that a single dose of diethylcarbamazine cleared microfilariae from the bloodstream within 24 hours and ivermectin resulted in a 1-log 10 decrease in the microfilariae count within the first 1 to 3 days after treatment.
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The current case suggests that it may be possible to lower L. loa microfilarial levels in the blood safely and slowly with a single oral dose of imatinib so that definitive diethylcarbamazine treat- reported scores on the Patient Health Questionnaire 9-item depression scale (PHQ-9) and the Veterans RAND 12-Item Health Survey (VR-12) that were similar between patients who received standard blood-pressure treatment and those who received intensive blood-pressure treatment, although they found significant differences in clinical outcomes. 2 These findings could be due to poor sensitivity of the patient-reported outcome instruments used. In their trial, summary scoring was used in a population with a considerable ceiling effect for satisfaction with bloodpressure care, satisfaction with medication, and PHQ-9 and VR-12 scores at baseline.
1 The ceiling effect further exacerbates the noise level in the measurement of patient-reported outcomes.
The sensitivity of an instrument for the measurement of patient-reported outcomes is lowest when summary scoring -the simple addition of ordinal values representing response categories -is used. Summary scoring assumes that response categories are equidistant from one another on a scale and that all items have the same worth. Item-response theory proves that neither assumption is valid. Therefore, these as- Copyright © 2017 Massachusetts Medical Society. All rights reserved.
